|
|
Volumn 314, Issue 16, 2015, Pages 1687-1688
|
|
Experience with the priority review voucher program for drug development
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALIROCUMAB;
ARTEMETHER PLUS BENFLUMETOL;
BEDAQUILINE;
CHOLIC ACID;
DINUTUXIMAB;
ELOSULFASE ALFA;
MILTEFOSINE;
MOXIDECTIN;
ANTIMALARIAL AGENT;
ANTINEOPLASTIC AGENT;
ANTIPROTOZOAL AGENT;
ARTEMISININ DERIVATIVE;
DRUG COMBINATION;
ETHANOLAMINE DERIVATIVE;
FLUORENE DERIVATIVE;
GALNS PROTEIN, HUMAN;
MONOCLONAL ANTIBODY;
N ACETYLGALACTOSAMINE 4 SULFATASE;
PHOSPHORYLCHOLINE;
QUINOLINE DERIVATIVE;
TUBERCULOSTATIC AGENT;
BILE ACID SYNTHESIS DISORDER;
BILIARY TRACT DISEASE;
CLINICAL EFFECTIVENESS;
COST BENEFIT ANALYSIS;
DEVELOPING COUNTRY;
DRUG MANUFACTURE;
DRUG MARKETING;
DRUG SAFETY;
EVIDENCE BASED MEDICINE;
FAMILIAL HYPERCHOLESTEROLEMIA;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE ACCESS;
HEALTH CARE PLANNING;
HEALTH CARE POLICY;
HUMAN;
MALARIA;
MORQUIO SYNDROME;
MULTIDRUG RESISTANT TUBERCULOSIS;
NEUROBLASTOMA;
ONCHOCERCIASIS;
PRIORITY JOURNAL;
PROGRAM DEVELOPMENT;
SCHISTOSOMIASIS;
SHORT SURVEY;
TROPICAL DISEASE;
TUBERCULOSIS;
VISCERAL LEISHMANIASIS;
YAWS;
ANALOGS AND DERIVATIVES;
DRUG APPROVAL;
DRUG COMBINATION;
DRUG INDUSTRY;
ECONOMICS;
LEGISLATION AND JURISPRUDENCE;
NEGLECTED DISEASES;
PROCEDURES;
RARE DISEASES;
UNITED STATES;
ANTIBODIES, MONOCLONAL;
ANTIMALARIALS;
ANTINEOPLASTIC AGENTS;
ANTIPROTOZOAL AGENTS;
ANTITUBERCULAR AGENTS;
ARTEMISININS;
CHOLIC ACID;
CHONDROITINSULFATASES;
DIARYLQUINOLINES;
DRUG APPROVAL;
DRUG COMBINATIONS;
DRUG INDUSTRY;
ETHANOLAMINES;
FLUORENES;
HUMANS;
NEGLECTED DISEASES;
PHOSPHORYLCHOLINE;
PROGRAM DEVELOPMENT;
RARE DISEASES;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 84945290539
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2015.11845 Document Type: Short Survey |
|
Times cited : (34)
|
|
References (8)
|
